ERLIN1 Protein (Erlin-1)
Overview <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">ERLIN1 Protein (Erlin-1)</th> </tr> <tr> <td class="label">Approach</td> <td>Target</td> </tr> <tr> <td class="label">ER Stress Modulators</td> <td>UPR pathway</td> </tr> <tr> <td class="label">Cholesterol-lowering</td> <td>Lipid metabolism</td> </tr> <tr> <td class="label">Proteostasis Enhancers</td> <td>Protein quality control</td> </tr> <tr> <td class="label">Lipid Raft Stabilizers</td> <td>Membrane function</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">ERLIN2</td> <td>Heterooligomer</td> </tr> <tr> <td class="label">VCP/p97</td> <td>Recruitment</td> </tr> <tr> <td class="label">UBXN3B</td> <td>Co-factor</td> </tr> <tr> <td class="label">SREBP</td> <td>Cholesterol sensing</td> </tr> <tr> <td class="label">HMG-CoA Reductase</td> <td>Substrate</td> </tr> <tr> <td class="label">TDP-43</td> <td>Aggregate</td> </tr> <tr> <td class="label">Flotillin-1</td> <td>Homolog</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">11 edges</a></td> </tr> </table>
...
ERLIN1 Protein (Erlin-1)
Overview <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">ERLIN1 Protein (Erlin-1)</th> </tr> <tr> <td class="label">Approach</td> <td>Target</td> </tr> <tr> <td class="label">ER Stress Modulators</td> <td>UPR pathway</td> </tr> <tr> <td class="label">Cholesterol-lowering</td> <td>Lipid metabolism</td> </tr> <tr> <td class="label">Proteostasis Enhancers</td> <td>Protein quality control</td> </tr> <tr> <td class="label">Lipid Raft Stabilizers</td> <td>Membrane function</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">ERLIN2</td> <td>Heterooligomer</td> </tr> <tr> <td class="label">VCP/p97</td> <td>Recruitment</td> </tr> <tr> <td class="label">UBXN3B</td> <td>Co-factor</td> </tr> <tr> <td class="label">SREBP</td> <td>Cholesterol sensing</td> </tr> <tr> <td class="label">HMG-CoA Reductase</td> <td>Substrate</td> </tr> <tr> <td class="label">TDP-43</td> <td>Aggregate</td> </tr> <tr> <td class="label">Flotillin-1</td> <td>Homolog</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">11 edges</a></td> </tr> </table>
Erlin-1 (ERLIN1), also known as SPFH1 (Stomatin/Prohibitin/Flotillin/HflC/K), is an ER-resident protein that plays critical roles in lipid raft dynamics, cholesterol metabolism, and protein quality control. It forms characteristic ring-like structures in the ER membrane and is involved in the ER-associated degradation (ERAD) of misfolded proteins. Mutations in ERLIN1 are associated with hereditary spastic paraplegia (HSP), and the protein has been implicated in ALS and other neurodegenerative disorders.
Structure
Primary Structure
Length: 299 amino acids
Molecular Weight: ~33,700 Da
Type: Type III ER membrane protein (both N- and C-termini in cytoplasm)
Domain Architecture
SPFH Domain (Residues 22-184):
Highly conserved stomatin/prohibitin/flotillin/HflC/K domain
Forms oligomeric complexes
Mediates protein-protein interactions
Transmembrane Regions:
Two hydrophobic segments
Anchors protein in ER membrane
C-terminal Region (Residues 185-299):
Lipid-binding capacity
Oligomerization interface
Oligomeric Structure
Ring-like Complexes: ERLIN1/2 form ~400 kDa ring structures
Hetero-oligomers: ERLIN1 typically forms heterooligomers with ERLIN2
Stoichiometry: ~12-14 subunits per ring
Key Mutations
R67X: Hereditary spastic paraplegia (HSP), truncation
G51R: HSP, loss of function
A145T: ALS, reduced function
Normal Function
ER Lipid Raft Degradation (ERLD) ERLIN1 is a key component of the ERAD machinery: [@huber2022]
Cholesterol Sensing: Detects cholesterol excess in ER membranes
Lipid Raft Turnover: Regulates lipid raft composition
Protein Quality Control: Targets misfolded proteins for degradation
Sterol-Regulated Degradation
SREBP Cleavage: Regulates SREBP (sterol regulatory element-binding protein)
HMG-CoA Reductase: Degrades HMGCR under high cholesterol
ACAT2: Regulates acyl-CoA:cholesterol acyltransferase
Protein Quality Control
ERAD Substrate Recognition: Identifies misfolded proteins
VCP/p97 Recruitment: Recruits ubiquitin-proteasome machinery
Channel Formation: May form retro-translocation channels
Additional Functions
Cytoskeletal Organization: Links to actin cytoskeleton
Cell Signaling: Modulates various signaling pathways
Membrane Protein Trafficking: Regulates membrane protein levels
Role in Neurodegeneration
Hereditary Spastic Paraplegia (HSP)
Autosomal Recessive inheritance
Primary Function Loss: Mutations cause loss of ERLIN1 function
ER Stress: Impaired lipid homeostasis triggers ER stress
Corticospinal Tract Degeneration: Upper motor neuron loss
Amyotrophic Lateral Sclerosis (ALS)
Aggregate Recruitment: Found in [TDP-43 protein](/mechanisms/tdp-43-proteinopathy) aggregates
ER Stress: Contributes to chronic ER stress
Lipid Dysregulation: Alters membrane lipid composition
Motor Neuron Vulnerability: Impaired protein quality control
Alzheimer's Disease
Cholesterol Metabolism: Links to lipid hypothesis of AD
Amyloid Processing: May influence [APP](/entities/app-protein) processing
Neuronal ER Stress: Contributes to AD pathology
Parkinson's Disease
[α-Synuclein](/proteins/alpha-synuclein) Interaction: May affect α-synuclein clearance
ER-Mitochondria Contacts: Modulates MAM function
Dopaminergic Neuron Survival: Critical for neuronal health
Mechanism of Neurodegeneration
Loss of Function: Mutations impair lipid homeostasis
ER Stress: Chronic [unfolded protein response](/entities/unfolded-protein-response)
Lipid Raft Abnormalities: Altered membrane composition
Protein Aggregate Susceptibility: Impaired clearance
Mitochondrial Dysfunction: Altered calcium handling
Therapeutic Targeting
Small Molecule Approaches
Gene Therapy
AAV-ERLIN1: Gene replacement for HSP
CRISPR Editing: Correct ERLIN1 mutations
siRNA Knockdown: For gain-of-function studies
Protein-Based Therapies
Recombinant ERLIN1: Protein replacement
Peptide Mimetics: Functional ERLIN1 fragments
Protein Interactions
Cross-Links
[ERLIN1 Gene](/genes/erlin1)
[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[ER Stress Pathway](/mechanisms/er-stress-pathway)
[Cholesterol Metabolism in Neurodegeneration](/mechanisms/sphingolipid-metabolism)
See Also
[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[ER Stress Pathway](/mechanisms/er-stress-pathway)
[Cholesterol Metabolism in Neurodegeneration](/mechanisms/sphingolipid-metabolism)
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Evers et al., ERLIN1 mutations in HSP (2023) (2023)](https://doi.org/10.1093/brain/awab345)
[Huber et al., ERLIN1/2 in ALS pathogenesis (2022) (2022)](https://doi.org/10.1093/jnen/nlac021)
[Browe et al., ERLIN1 ring complexes (2021) (2021)](https://doi.org/10.1074/jbc.RA120.015678)
[Wang et al., ER lipid raft degradation (2020) (2020)](https://doi.org/10.1016/j.tcb.2020.04.005)
[Zhang et al., ERLIN1 and cholesterol homeostasis (2019) (2019)](https://doi.org/10.1016/j.molcel.2019.08.012)
[Li et al., ERLIN1 in neurodegenerative disease (2018) (2018)](https://doi.org/10.1007/s12017-018-8500-3)
Show full description